| David Pascoe, MD | |
|
1981 Capital Cir Ne, Tallahassee, FL 32308-4421 | |
| (850) 402-9444 | |
| (850) 402-0188 |
| Full Name | David Pascoe |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 20 Years |
| Location | 1981 Capital Cir Ne, Tallahassee, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003038555 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | ME101486 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Family Dermatology Of North Florida Llc | 0749619302 | 3 |
News Archive
The Food and Drug Administration in the U.S. has given it's approval for the multiple sclerosis drug Tysabri to be put back on the market.
Mental disorders, such as depression, anxiety disorders, addiction and schizophrenia are the core challenge of most health care systems around the world. In the EU alone, each year 27% of the total adult population - this corresponds to 83 Million citizens - suffer from mental disorders. Depression alone affects almost 20 million ranking in the EU as the most disabling disorder of all diseases.
Scientists at the University of Liverpool have developed a new X-ray technique to identify tissue fibres in the heart that ensure the muscle beats in a regular rhythm.
Florida Hospital Celebration Health announced this week the use of a new class of flexible surgical instruments created by Apollo Endosurgery®, to remove a stomach tumor and extract it through the patient's mouth. Following the two-hour surgery, the patient spent one night in the hospital and was prescribed Acetaminophen for pain.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that new clinical data from a Phase 1b trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with paclitaxel (Taxol), a standard chemotherapy regimen, will be presented during the 33rd Annual San Antonio Breast Cancer Symposium (SABCS) being held December 8-12, 2010 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
› Verified 1 days ago
| Entity Name | Family Dermatology Of North Florida Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033752969 PECOS PAC ID: 0749619302 Enrollment ID: O20200402000002 |
News Archive
The Food and Drug Administration in the U.S. has given it's approval for the multiple sclerosis drug Tysabri to be put back on the market.
Mental disorders, such as depression, anxiety disorders, addiction and schizophrenia are the core challenge of most health care systems around the world. In the EU alone, each year 27% of the total adult population - this corresponds to 83 Million citizens - suffer from mental disorders. Depression alone affects almost 20 million ranking in the EU as the most disabling disorder of all diseases.
Scientists at the University of Liverpool have developed a new X-ray technique to identify tissue fibres in the heart that ensure the muscle beats in a regular rhythm.
Florida Hospital Celebration Health announced this week the use of a new class of flexible surgical instruments created by Apollo Endosurgery®, to remove a stomach tumor and extract it through the patient's mouth. Following the two-hour surgery, the patient spent one night in the hospital and was prescribed Acetaminophen for pain.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that new clinical data from a Phase 1b trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with paclitaxel (Taxol), a standard chemotherapy regimen, will be presented during the 33rd Annual San Antonio Breast Cancer Symposium (SABCS) being held December 8-12, 2010 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Pascoe, MD 1981 Capital Cir Ne, Tallahassee, FL 32308-4421 Ph: (850) 402-9444 | David Pascoe, MD 1981 Capital Cir Ne, Tallahassee, FL 32308-4421 Ph: (850) 402-9444 |
News Archive
The Food and Drug Administration in the U.S. has given it's approval for the multiple sclerosis drug Tysabri to be put back on the market.
Mental disorders, such as depression, anxiety disorders, addiction and schizophrenia are the core challenge of most health care systems around the world. In the EU alone, each year 27% of the total adult population - this corresponds to 83 Million citizens - suffer from mental disorders. Depression alone affects almost 20 million ranking in the EU as the most disabling disorder of all diseases.
Scientists at the University of Liverpool have developed a new X-ray technique to identify tissue fibres in the heart that ensure the muscle beats in a regular rhythm.
Florida Hospital Celebration Health announced this week the use of a new class of flexible surgical instruments created by Apollo Endosurgery®, to remove a stomach tumor and extract it through the patient's mouth. Following the two-hour surgery, the patient spent one night in the hospital and was prescribed Acetaminophen for pain.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that new clinical data from a Phase 1b trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with paclitaxel (Taxol), a standard chemotherapy regimen, will be presented during the 33rd Annual San Antonio Breast Cancer Symposium (SABCS) being held December 8-12, 2010 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
› Verified 1 days ago
Dr. Armand B Cognetta Jr., M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1707 Riggins Rd, Tallahassee, FL 32308 Phone: 850-877-4134 Fax: 850-402-9130 | |
Dr. William Harris Green, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1707 Riggins Rd, Tallahassee, FL 32308 Phone: 850-877-4134 Fax: 850-402-9130 | |
Pamela Schofield Kennedy, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1355 Thomaswood Dr, Tallahassee, FL 32308 Phone: 850-656-4555 Fax: 850-656-4557 | |
Emily Jacox, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 2626 Capital Medical Blvd, Tallahassee, FL 32308 Phone: 850-325-5000 | |
Dr. Oen-hiang Cynthia Tie, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1981 Capital Cir Ne, Tallahassee, FL 32308 Phone: 850-402-9444 Fax: 850-402-0188 | |
Michael Jay Bernhardt, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1626 Riggins Rd, Tallahassee, FL 32308 Phone: 850-877-4134 Fax: 850-402-9130 |